Kovack Advisors’s Immuneering IMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$144K Buy
+35,700
New +$169K 0.01% 1011

Other funds holding IMRX

Kovack Advisors's IMRX Position: Q3 2026 in Review

Kovack Advisors opened a new position in Immuneering (IMRX) in Q3 2026: 35,700 shares worth $144K. The stake represents 0.01% of the portfolio and ranks #1011 among its holdings.

131 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.

  • Kovack Advisors held 35,700 shares of Immuneering worth $144K as of Q3 2026.
  • Immuneering was a new Kovack Advisors position in Q3 2026.
  • Immuneering made up 0.01% of Kovack Advisors's portfolio in Q3 2026, its #1011 holding.
  • 131 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.

Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.